Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | palmitoleic acid | 144 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 211 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 217 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 218 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 227 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 258 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 259 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 260 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 268 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 275 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 275 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 276 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 278 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 278 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 282 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 288 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 288 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 295 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 300 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 300 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 314 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 314 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 315 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 317 | Counts | 50-54 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 319 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 321 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 325 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 325 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 326 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 326 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 332 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 333 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 334 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 334 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 335 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 340 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 343 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 346 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 352 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 356 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 357 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 357 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 357 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 361 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 363 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 367 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 369 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 371 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 372 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 376 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 378 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 381 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 381 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 381 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 384 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 387 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 389 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 390 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 393 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 394 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 397 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 404 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 408 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 409 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 410 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 420 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 423 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 423 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 430 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 438 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 439 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 441 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 449 | Counts | 65-69 | Female | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 452 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 462 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 464 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 465 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 470 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 471 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 472 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 473 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 478 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 479 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 479 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 483 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 487 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 487 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 491 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 501 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 503 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 507 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 508 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 513 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 516 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 521 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 528 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 533 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 534 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 540 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 542 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 551 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 555 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 556 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 559 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 560 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 560 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 565 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 567 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 568 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 572 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 576 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 579 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 582 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 585 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 590 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 593 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 594 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 595 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 601 | Counts | 55-59 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 605 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 607 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 609 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 614 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 614 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 618 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 622 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 625 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 628 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 633 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 642 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 649 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 651 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 653 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 654 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 656 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 660 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 662 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 665 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 667 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 674 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 676 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 685 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 688 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 688 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 702 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 703 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 706 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 709 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 721 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 721 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 729 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 740 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 742 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 746 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 758 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 759 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 762 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 764 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 764 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 776 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | palmitoleic acid | 790 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 804 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 805 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 814 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 819 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 824 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 834 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 842 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 845 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 883 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 890 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 892 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 907 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 908 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 911 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 920 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 929 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 937 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 941 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 941 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 946 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 951 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 970 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 970 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 972 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 976 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 982 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | palmitoleic acid | 986 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 989 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 992 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 1001 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 1020 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 1027 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 1038 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 1041 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 1058 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | palmitoleic acid | 1062 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 1071 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | palmitoleic acid | 1121 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | palmitoleic acid | 1137 | Counts | 55-59 | Male | Former | - |
Return to search page